NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis $2.42 0.00 (0.00%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$2.43 +0.01 (+0.29%) As of 10/23/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About Autonomix Medical Stock (NASDAQ:AMIX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Autonomix Medical alerts:Sign Up Key Stats Today's Range$2.42▼$2.5050-Day Range$2.42▼$7.1952-Week Range$2.41▼$32.55Volume59,958 shsAverage Volume199,052 shsMarket Capitalization$2.35 millionP/E RatioN/ADividend YieldN/APrice Target$42.00Consensus RatingHold Company Overview Autonomix Medical, Inc. is a clinical-stage medical device company developing catheter-based technologies for the diagnosis and treatment of conditions involving the peripheral and autonomic nervous systems. Its platform is designed to help physicians identify and access nerves during minimally invasive procedures. The company’s technology incorporates a miniature sensor into a catheter to detect neural signals in real time. Autonomix is initially focused on applications in pain management, including procedures intended to treat pain associated with pancreatic cancer, while also evaluating broader uses in chronic pain and other conditions involving abnormal nerve activity. Autonomix Medical’s products are in the development and clinical-evaluation stages, and the company’s technology may require additional testing, regulatory review and approval before broader commercialization. Publicly available information provides limited detail about its commercial geographic reach and operating history.AI Generated. May Contain Errors. Read More Autonomix Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreAMIX MarketRank™: 2.92562542258 of 5 starsAutonomix Medical scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAutonomix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialAutonomix Medical has a consensus price target of $42.00, representing about 1,635.5% upside from its current price of $2.42.Amount of Analyst CoverageAutonomix Medical has only been the subject of 1 research reports in the past 90 days.Read more about Autonomix Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Autonomix Medical are expected to grow in the coming year, from ($20.17) to ($17.44) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Autonomix Medical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Autonomix Medical is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAutonomix Medical has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Autonomix Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.92% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 0.24, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently decreased by 56.32%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAutonomix Medical does not currently pay a dividend.Dividend GrowthAutonomix Medical does not have a long track record of dividend growth. News and Social Media1.8 / 5News SentimentN/A News SentimentAutonomix Medical has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Autonomix Medical this week, compared to 3 articles on an average week.Search Interest6 people have searched for AMIX on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Autonomix Medical insiders have not sold or bought any company stock.Percentage Held by Insiders5.50% of the stock of Autonomix Medical is held by insiders.Percentage Held by Institutions10.78% of the stock of Autonomix Medical is held by institutions.Read more about Autonomix Medical's insider trading history. Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMIX Stock News HeadlinesAutonomix Medical consensus price target lowered by 30.61% to $41.62October 22, 2026 | msn.comAutonomix Medical, Inc. (AMIX) Receives a Buy from Maxim GroupOctober 18, 2026 | theglobeandmail.comWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7. | Porter & Company (Ad)Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural ValidationOctober 2, 2026 | globenewswire.comAutonomix Medical Completes FDA Pre-Submission Meeting On Standalone Transvascular Sensing PlatformSeptember 30, 2026 | rttnews.comAutonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. ClearanceSeptember 30, 2026 | globenewswire.comAutonomix Medical Receives European Patent For Neural Activity Assessment TechnologySeptember 26, 2026 | rttnews.comAMIX Share News TodaySeptember 24, 2026 | uk.investing.comSee More Headlines AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed this year? Autonomix Medical's stock was trading at $11.55 at the start of the year. Since then, AMIX stock has decreased by 79.0% and is now trading at $2.42. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) posted its quarterly earnings data on Wednesday, August, 12th. The company reported ($5.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($6.40) by $1.38. When did Autonomix Medical's stock split? Shares of Autonomix Medical reverse split before market open on Wednesday, June 24th 2026.A 1-21 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an IPO on the week of January 29th 2024. The company issued 2,234,222 shares at a price of $5.00 per share. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Autonomix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Autonomix Medical investors own include Tesla (TSLA), Archer Aviation (ACHR), ExxonMobil (XOM), Barrick Mining (B), Chevron (CVX), Aquestive Therapeutics (AQST) and BioCryst Pharmaceuticals (BCRX). Company Calendar Last Earnings8/12/2026Today10/26/2026Next Earnings (Estimated)11/11/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 AMIX's financial health is in the Yellow zone, according to TradeSmith. AMIX has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees11Year FoundedN/APrice Target and Rating Average Price Target for Autonomix Medical$42.00 High Price Target$42.00 Low Price Target$42.00 Potential Upside/Downside+1,635.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($41.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$16.72 million Net MarginsN/A Pretax MarginN/A Return on Equity-267.73% Return on Assets-216.75% Debt Debt-to-Equity RatioN/A Current Ratio4.85 Quick Ratio4.85 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$10.85 per share Price / Book0.22Miscellaneous Outstanding Shares970,000Free Float918,000Market Cap$2.35 million OptionableN/A Beta-0.96 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:AMIX) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredForget the AI predictions. Look at the incomeAI predictions are everywhere, but Tim Plaehn is focused on something concrete: income. He's found a small ...Investors Alley | SponsoredFinally… options made simpleIan Cooper once believed successful options trading meant endless chart-watching, complex strategies, and big ...TradeWins | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredAsk a 20 Year Trading Pro Your Stock Questions Live for 5Ross Givens, a market analyst with over 20 years on Wall Street, goes live every Monday at 9 AM ET to break do...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
